Literature DB >> 17157603

Age-related macular degeneration is associated with an increased risk of hip fractures in the Medicare database.

Eleftherios Anastasopoulos1, Fei Yu, Anne L Coleman.   

Abstract

PURPOSE: To explore the relationship between age-related macular degeneration (AMD) and incident hip fractures in the Medicare population.
DESIGN: Prospective cohort study.
METHODS: With a 5% random sample of Medicare beneficiaries in 1995, 8596 cases were coded with exudative AMD; 26,942 cases were coded with atrophic AMD, and 1,013,748 cases were coded without AMD. The Medicare claims from 1996 to 1999 were evaluated for hip fracture codes. The relationship between AMD and incident hip fractures was analyzed with multiple logistic regression models, with adjustment for baseline, ocular, and systemic covariates.
RESULTS: In adjusted analyses, the risk of hip fractures was similar in cases that were coded with exudative AMD (odds ratio, 1.03; 95% confidence interval (CI), 0.95, 1.12) compared with cases with no AMD but was significantly higher in cases that were coded with atrophic AMD (odds ratio, 1.11; 95% CI, 1.06, 1.16).
CONCLUSION: Medicare patients with a code for atrophic AMD had an 11% greater risk of hip fractures than did patients without a code for AMD over a four-year follow-up period.

Entities:  

Mesh:

Year:  2006        PMID: 17157603     DOI: 10.1016/j.ajo.2006.06.058

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  14 in total

1.  Risk of musculoskeletal injuries, fractures, and falls in medicare beneficiaries with disorders of binocular vision.

Authors:  Stacy L Pineles; Michael X Repka; Fei Yu; Flora Lum; Anne L Coleman
Journal:  JAMA Ophthalmol       Date:  2015-01       Impact factor: 7.389

Review 2.  Use of health care claims data to study patients with ophthalmologic conditions.

Authors:  Joshua D Stein; Flora Lum; Paul P Lee; William L Rich; Anne L Coleman
Journal:  Ophthalmology       Date:  2014-01-14       Impact factor: 12.079

3.  Longitudinal incidence of adverse outcomes of age-related macular degeneration.

Authors:  Ashley Wysong; Paul P Lee; Frank A Sloan
Journal:  Arch Ophthalmol       Date:  2009-03

4.  Visual field loss and risk of fractures in older women.

Authors:  Anne L Coleman; Steven R Cummings; Kristine E Ensrud; Fei Yu; Peter Gutierrez; Katie L Stone; Jane A Cauley; Kathryn L Pedula; Marc C Hochberg; Carol M Mangione
Journal:  J Am Geriatr Soc       Date:  2009-08-21       Impact factor: 5.562

5.  [Challenges in inpatient ophthalmology for elderly patients].

Authors:  M Pietzsch; I Moros; A Just; C Wirbelauer
Journal:  Ophthalmologe       Date:  2014-08       Impact factor: 1.059

6.  Sources of binocular suprathreshold visual field loss in a cohort of older women being followed for risk of falls (an American Ophthalmological Society thesis).

Authors:  Anne Louise Coleman
Journal:  Trans Am Ophthalmol Soc       Date:  2007

7.  [Demographic change : challenges to ophthalmological patient-centered care].

Authors:  W Hoffmann; N van den Berg; U Stentzel; R Großjohann; C Jürgens; F Tost
Journal:  Ophthalmologe       Date:  2014-05       Impact factor: 1.059

8.  The Prevalence of Visual Impairment in Retirement Home Residents.

Authors:  Luisa Thederan; Susanne Steinmetz; Sabine Kampmann; Anna-Maria Koob-Matthes; Franz Grehn; Thomas Klink
Journal:  Dtsch Arztebl Int       Date:  2016-05-06       Impact factor: 5.594

9.  Age Related Macular Degeneration and Total Hip Replacement Due to Osteoarthritis or Fracture: Melbourne Collaborative Cohort Study.

Authors:  Elaine W Chong; Yuanyuan Wang; Liubov D Robman; Khin Zaw Aung; Galina A Makeyeva; Graham G Giles; Stephen Graves; Flavia M Cicuttini; Robyn H Guymer
Journal:  PLoS One       Date:  2015-09-10       Impact factor: 3.240

10.  History of falling and visual ability among independently living elderly in Sweden.

Authors:  Jeanette Källstrand-Eriksson; Cathrine Hildingh; Boel Bengtsson
Journal:  Clin Ophthalmol       Date:  2016-07-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.